PHVS
Pharvaris N.V. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website arvaris.com
- Employees(FY) 70
- ISIN NL00150005Y4
Performance
-15.21%
1W
-7.58%
1M
-29.39%
3M
+20.03%
6M
-25.67%
YTD
+125.16%
1Y
Profile
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.
Investment Analysis Report: PHVS
Overview
PHVS is a pharmaceutical company operating in the Health Technology sector, with a market capitalization of $1.1 billion. The company's financial data provides insights into its valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital exp...
Technical Analysis of PHVS 2024-05-03
Overview:
In analyzing the technical indicators for PHVS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-04-12 07:54
- 2024-04-10 16:10
- 2024-04-10 16:08
- 2024-04-10 09:52
PHVS Stock Earnings: Pharvaris Misses EPS for Q4 2023(Investorplace)
- 2024-04-10 04:10
- 2024-04-10 04:08
- 2024-04-04 06:50
- 2024-04-03 18:50
- 2024-03-18 06:50
- 2024-03-17 18:50
- 2024-03-06 06:50
- 2024-03-05 17:50
- 2024-03-05 06:50
- 2024-03-04 17:50
- 2024-02-22 06:50
- 2024-02-21 17:50
- 2024-02-16 06:50
Pharvaris Announces Extraordinary Meeting of Shareholders(GlobeNewswire)
- 2024-02-15 17:50
Pharvaris Announces Extraordinary Meeting of Shareholders(Globenewswire)
- 2024-01-26 06:50
Pharvaris to Present at the WSAAI Annual Meeting 2024(GlobeNewswire)
- 2024-01-25 17:50
Pharvaris to Present at the WSAAI Annual Meeting 2024(Globenewswire)
- 2024-01-23 09:34
- 2024-01-22 20:34
- 2024-01-22 16:07
Top-Notch Pharvaris Eyes Profit-Taking Zone On A Key FDA Decision(Investor's Business Daily)
- 2024-01-22 06:50
- 2024-01-21 18:34
- 2024-01-21 17:50
- 2024-01-05 06:50
- 2024-01-04 17:50
- 2023-12-11 06:56
- 2023-12-08 18:00
Page 1 of 5
previousnext